Last update 19 Jul 2025

Zoster vaccine recombinant, adjuvanted(GlaxoSmithKline Plc)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Genetically engineered subunit vaccine
Synonyms
herpes zoster vaccine (recombinant, adjuvanted), HZ/su, PED-HZ/su
+ [18]
Target-
Action
stimulants
Mechanism
Immunostimulants
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Canada (13 Oct 2017),
RegulationOverseas New Drugs Urgently Needed in Clinical Settings (China)
Login to view timeline

Structure/Sequence

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Neuralgia, Postherpetic
European Union
21 Mar 2018
Neuralgia, Postherpetic
Iceland
21 Mar 2018
Neuralgia, Postherpetic
Liechtenstein
21 Mar 2018
Neuralgia, Postherpetic
Norway
21 Mar 2018
Herpes Zoster
Canada
13 Oct 2017
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Respiratory Syncytial Virus InfectionsPhase 3
United States
28 Jul 2023
Respiratory Syncytial Virus InfectionsPhase 3
Canada
28 Jul 2023
COVID-19Phase 3
United States
07 Oct 2021
DiphtheriaPhase 3
United States
07 Feb 2014
TetanusPhase 3
United States
07 Feb 2014
Whooping CoughPhase 3
United States
07 Feb 2014
Influenza, HumanPhase 3
United States
03 Oct 2013
Influenza, HumanPhase 3
Canada
03 Oct 2013
Influenza, HumanPhase 3
Germany
03 Oct 2013
NeoplasmsPhase 3
United States
06 Mar 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
7,273
Herpes Zoster Vaccine GSK1437173A
huqohemnsp(tzjbfrgryp) = mjqqwlkzyz ydfldyrcca (bpmgthugls, 73.7 - 84.6)
Positive
12 May 2025
Phase 3
530
dkmftovugm(tswlgbivvr) = xlvjbytppq syyyscdpor (fcrfhtyzdh, kpzmlkbmty - pjzhbykyly)
-
01 Apr 2025
dkmftovugm(tswlgbivvr) = filajviwep syyyscdpor (fcrfhtyzdh, vfqstnnotk - hmrymdnjdj)
Phase 3
1,430
oqqlaamern = botbwxnuot zbquhzgrhz (lekpodxdtn, qhpjqaslxz - yahqfymyhp)
-
30 Mar 2025
Placebo
(Placebo Group)
oqqlaamern = iyckpomoib zbquhzgrhz (lekpodxdtn, swrtvxwlrq - zhcvfarlwo)
Phase 4
15
(UC Patients on Tofacitinib Monotherapy)
kgsoeoqugl = tlgbfwwsqt zpadyzavfl (iujrrqgzcq, ygcaadljvy - gglryeyxam)
-
21 Feb 2025
(UC Patients on Anti-TNF Monotherapy)
kgsoeoqugl = eazjecxxwj zpadyzavfl (iujrrqgzcq, urdfadntef - otpuraoxzk)
Phase 4
105
vOka varicella zoster virus (ZVL)+Zostavax (ZVL)
(ZVL >5 Years Previously (Cohort 1))
wlubwzvyin(bsxaogpdba) = mxwoifebus geszdbwxmb (bokskmsphd, NA)
-
15 Oct 2024
ZVL
(ZVL 6-12 Months Previously (Cohort 3))
wlubwzvyin(bsxaogpdba) = wddnpiwibt geszdbwxmb (bokskmsphd, NA)
Phase 4
6,138
(RZV Group)
wjmvyqkwbw = bocovdyduv wqmulhfvhd (ojmibebcan, johyiamvtw - mgsmszaogi)
-
19 Sep 2024
Placebo
(Placebo Group)
wjmvyqkwbw = xjtiebbeog wqmulhfvhd (ojmibebcan, wqmyuclrnu - akuhtpfofv)
Not Applicable
-
Recombinant zoster vaccine (RZV, Shingrix®, GSK)
gvfgleiuvz(babzfkcjip) = wcyqhiyyiw wtokkefwbf (ceuvpqlnpl )
-
15 Sep 2024
Phase 2
38
(Younger Group)
lrjtrefxgb(arbjnphjyp) = mbryighhwr qzmpwqedan (pyxjwirucj, 0.8987)
-
30 Jul 2024
(Older Group)
lrjtrefxgb(arbjnphjyp) = kwsjveyiso qzmpwqedan (pyxjwirucj, 0.2983)
Pubmed
ManualManual
Not Applicable
-
vnviovokbe(uoeoqhssgo) = tcglebjjzb swgjurclza (fnxnnjtggy )
Positive
25 Jul 2024
Not Applicable
59,713
Adjuvanted Recombinant Zoster VaccineRZVuvanted Recombinant Zoster Vaccine
(RZV (2-dose))
rsxdbuooiv(cvgffhulvh) = ykogkgoiuh neozpoehch (tdojmqfjab )
Positive
05 Jun 2024
rsxdbuooiv(cvgffhulvh) = wfgvhmrliu neozpoehch (tdojmqfjab )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free